Precision Treatment and Translational Data Integration for Sarcomas and Rare Cancers | ATLAS Webinar Jan 2026

[Topic] Precision Treatment and Translational Data Integration for Sarcomas and Rare Cancers[Date] 28 January 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 0:06:25～Precision radiotherapy for sarcomas and other rare cancersSpeaker: Dr. Wong Ru Xin(Icon Cancer Centre, Singapore)[Lecture 2] 0:26:10~Data Integration & Multi-Institutional Efforts for Translational Sarcoma ResearchSpeaker: Dr. Woo Xing Yi(A*STAR Bioinformatics Institute, Singapore)[Discussion] 0:52:13~DiscussionFacilitator: Dr. Valerie Yang Shiwen(OncoCare Cancer Centre, Singapore)

Biliary Tract Cancer (BTC) | ATLAS Webinar Feb 2026

[Topic] Biliary Tract Cancer (BTC)[Date] 26 February 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 0:08:40~Epidemiology and Clinical Practice of Biliary Tract Cancer in Southeast AsiaSpeaker: Dr. Thanachai Sanlung(Khon Kaen University, Thailand)[Lecture 2] 0:34:14~Current Standard and Future Perspectives of Immunotherapy for BTCSpeaker: Dr. Do-Youn Oh(Seoul National University Hospital, South Korea)[Discussion] 1:13:44~ DiscussionFacilitator: Dr. Li-Tzong Chen(Kaohsiung Medical University Chung-Ho Memorial Hospital, Taiwan)Facilitator: Dr. Chigusa Morizane(National Cancer Center, Japan)

US & UK Clinical Trial Environment | ATLAS Webinar Mar 2026

[Topic] US & UK Clinical Trial Environment[Date] 12 March 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 0:07:24~Navigating the US Clinical Trial Landscape: Operations, Regulations, and FinancialsSpeaker: Ms. Tomomi Hata(National Cancer Center, Japan)[Lecture 2] 0:32:45~Clinical Research in the UK: The Centralized NHS Model and Evolving Regulatory PathwaysSpeaker: Ms. Celia St Clair(National Cancer Center, Japan)[Discussion] 1:02:35~ DiscussionFacilitator: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)

Immunotherapy in treatment of locally advanced SCCHN - current paradigms and unmet needs | ATLAS Webinar Apr 2026

[Topic] Immunotherapy in treatment of locally advanced SCCHN - current paradigms and unmet needs[Date] 24 April 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Mitsumi Terada(Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)[Lecture 1] 0:05:41~Perioperative immunotherapy in head and neck cancer – hope or hypeSpeaker: Dr. Gopal Iyerw（National Cancer Centre, Singapore)[Lecture 2] 0:23:44~Current Status and Future Directions of Combination Therapy in HNSCC: Strategic Optimization in Locally-Advanced and Recurrent or Metastatic Disease Speaker: Dr. Kao Hsiang Fong(National Taiwan University Hospital, Taiwan)[Discussion] 0:42:11~DiscussionFacilitator: Dr. Mitsumi Terada(Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)